IMUX
Immunic Inc
9.40$
-13.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | 0.00 | – | – | |
| -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | 0.00 | – | – | |
| 4.44 | 4.32 | 1.93 | 1.81 | 2.11 | 2.40 | 2.12 | 1.62 | 1.03 | 1.58 | 0.85 | 0.61 | 2.13 | |
| 0.85 | 0.92 | 0.53 | 0.44 | 0.43 | 0.45 | 0.52 | 0.43 | 0.31 | 0.35 | 0.25 | 0.22 | 0.64 | |
| 5.29 | 5.23 | 2.45 | 2.25 | 2.54 | 2.84 | 2.65 | 2.05 | 1.34 | 1.94 | 1.10 | 0.83 | 2.77 | |
| -5.29 | -5.24 | -2.45 | -2.25 | -2.54 | -2.84 | -2.65 | -2.05 | -1.34 | -1.94 | -1.10 | -0.83 | -2.77 | |
| – | 0.45 | – | – | – | – | – | – | – | – | – | – | – | |
| -5.11 | -4.83 | -3.04 | -2.11 | -2.41 | -2.79 | -2.51 | -2.03 | -1.32 | -1.60 | -1.08 | -0.80 | -2.62 | |
| -0.17 | 0.84 | 0.00 | – | – | 0.00 | – | – | – | – | – | – | – | |
| -5.11 | -4.83 | -3.04 | -2.11 | -2.41 | -2.79 | -2.51 | -2.03 | -1.32 | -1.60 | -1.08 | -0.80 | -2.62 | |
| -5.10 | -4.83 | -3.04 | -2.11 | -2.40 | -2.79 | -2.51 | -2.03 | -1.32 | -1.60 | -1.08 | -0.80 | -2.62 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.